These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7333989)

  • 1. The penetration of cefoxitin into peritoneal fluid.
    Wise R; Donovan IA; Ambrose NS; Allcock JE
    J Antimicrob Chemother; 1981 Dec; 8(6):453-7. PubMed ID: 7333989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the transperitoneal passage of cefoxitin in the ascitic cirrhotic patient].
    Bourreille J; Le Bihan G; Beau B; Leroy A; Humbert G; Barthes PX
    Med Chir Dig; 1979; 8(7):667-70. PubMed ID: 537415
    [No Abstract]   [Full Text] [Related]  

  • 3. Disposition of cefoxitin in patients with ascites.
    Garcia MJ; Dominguez-Gil A; Perez FD; Rodriguez FP; Moronta FD
    Eur J Clin Pharmacol; 1981; 20(5):371-4. PubMed ID: 7286047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of free and liposomal cefoxitin in plasma and peritoneal fluid in a porcine intra-abdominal sepsis model.
    Shek PN; Tikuisis P; Zamecnik J; Soltes S; Mustard RA; Mittelman MW
    J Drug Target; 1998; 5(5):353-64. PubMed ID: 9771617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of clindamycin, cefoxitin, and metronidazole into pelvic peritoneal fluid of women undergoing diagnostic laparoscopy.
    Berger SA; Kupferminc M; Lessing JB; Gorea A; Gull I; Peyser MR
    Antimicrob Agents Chemother; 1990 Feb; 34(2):376-7. PubMed ID: 2139315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal penetration of ciprofloxacin.
    Lockley MR; Waldron R; Wise R; Donovan IA
    Eur J Clin Microbiol; 1986 Apr; 5(2):209-10. PubMed ID: 2941284
    [No Abstract]   [Full Text] [Related]  

  • 8. Penetration of four cephalosporins into tissue fluid in man.
    Gillett AP; Wise
    Lancet; 1978 May; 1(8071):962-4. PubMed ID: 76892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of cefbuperazone, a new cephamycin antibiotic, into human peritoneal exudate].
    Watanabe Y; Gonda A; Kidokoro T
    Jpn J Antibiot; 1984 Feb; 37(2):261-6. PubMed ID: 6737691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man.
    Brattström C; Malmborg AS; Tydén G
    Surgery; 1988 May; 103(5):563-7. PubMed ID: 3283981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intraperitoneal penetration of temocillin.
    Wise R; Donovan IA; Drumm J; Dyas A; Cross C
    J Antimicrob Chemother; 1983 Jul; 12(1):93-6. PubMed ID: 6619048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal penetration of meropenem.
    Hextall A; Andrews JM; Donovan IA; Wise R
    J Antimicrob Chemother; 1991 Aug; 28(2):314-6. PubMed ID: 1778863
    [No Abstract]   [Full Text] [Related]  

  • 17. The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease.
    Rolando N; Wade JJ; Philpott-Howard JN; Casewell MW; Williams R
    J Antimicrob Chemother; 1994 Jan; 33(1):163-7. PubMed ID: 8157557
    [No Abstract]   [Full Text] [Related]  

  • 18. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
    Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and body fluid and endometrial concentrations of cefoxitin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Aug; 47(8):1734-8. PubMed ID: 3752682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal elimination of cefoxitin and effect of probenecid after single and repeated doses.
    Arvidsson A; Borgå O; Kager L; Pieper R
    J Antimicrob Chemother; 1981 Apr; 7(4):423-30. PubMed ID: 7019188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.